The present invention provides transgenic mice deficient in urocortin.
Urocortin null mutant mice are hypersensitive to stress and display
heightened anxiety-like behaviors in the elevated plus maze and open
field tests. These mice also demonstrate physiological alterations in
auditory thresholds and distortion product otoacoustic emissions. These
results indicate that urocortin plays a modulatory role in
anxiety-related behaviors and in contributing to the establishment of
auditory thresholds. Such urocortin deficient mutant mice can provide
useful models in the study of anxiety pathology and hearing physiology at
the biochemical and molecular levels.